SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France - 20/11/22
, E. Tadié b, C. Heslan b, P. Gary-Bobo b, S. Oumari b, A. Saade a, A. Sitruk a, P. Tattevin c, V. Thibault a, C. Paris aThe AntiCOV-HB* working group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Among healthcare workers (HCWs) in France after the first COVID-19 wave, SARS-CoV-2 IgG rate was 1.06% [0.86%–1.27%]. |
• | Contact with HCWs or household members with COVID-19 was associated with IgG presence. |
• | Total SARS-CoV-2 antibodies decreased between day 0 and day 90 and with anosmia or ageusia. |
• | Total SARS-CoV-2 antibodies were higher in HCWs older than 50 years. |
Abstract |
Objectives |
To estimate the SARS-CoV-2 IgG seroprevalence rate in healthcare workers (HCWs) from Western France after the first 2020 wave, its determinants and the kinetics of total SARS-CoV-2 antibodies.
Patients and methods |
Overall, 9,453 HCWs responded to a self-questionnaire and underwent a lateral flow immunoassay to assess SARS-CoV-2 IgG presence. For 72 HCWs who tested positive, total anti-nucleocapsid antibodies were assessed at day 0, 30, and 90.
Results |
SARS-CoV-2 IgG seroprevalence rate was 1.06 % [0.86 %–1.27 %]. Factors associated with IgG presence were gender, performing upper respiratory tract samples, contact with HCWs or household members diagnosed with COVID-19. Total antibodies decreased between day 0 and day 90, with anosmia or ageusia, and were higher in HCWs older than 50 years.
Conclusion |
We reported a low prevalence rate of IgG and identified several risk factors associated with its presence and persistence of total antibodies. Additional studies are needed to confirm these observations.
Le texte complet de cet article est disponible en PDF.Keywords : SARS-CoV-2, Seroprevalence survey, Occupational exposure, Health care workers
Plan
Vol 52 - N° 8
P. 447-452 - novembre 2022 Retour au numéro
Article précédent
- Corynebacterium glucuronolyticum in men with and without urethritis syndrome: An underrecognized pathogen or a bona fide commensal?
- T. Meštrović, M. Neuberg, M. Sviben, R. Ribić, D. Drenjančević, I. Škrlec, J. Talapko, G. Kozina, Z. Profozić
- Use of RT-PCR thermocycling program for the quantification of DNA viruses in a single run with RNA viruses: Example of Altona RealStar® HSV or VZV PCR kits
- Julien Andreani, Julien Lupo, Benjamin Nemoz, Aurelie Truffot, Sylvie Larrat, Patrice Morand, Raphaële Germi
Bienvenue sur EM-consulte, la référence des professionnels de santé.